What question did this study set out to answer?

The research aims to investigate the risk of herpes zoster among adults starting immunosuppressive therapy.

March 28, 2026Journal of Managed Care & Specialty Pharmacy0 citations

Risk of herpes zoster among adults in the United States initiating immunosuppressive therapy: A retrospective cohort study

JCJustin CarricoNorth Carolina Central University YZYong ZhuOptum (United States)ASAndrea Steffens

Puntos clave

The research aims to investigate the risk of herpes zoster among adults starting immunosuppressive therapy.
Conducted a retrospective cohort study
Analyzed data from adults initiating immunosuppressive therapy
Evaluated the incidence of herpes zoster and related complications
Found a higher risk of herpes zoster in patients using immunosuppressive medications
Identified significant complications associated with herpes zoster in this population

Resumen

Immunosuppressive medication use was associated with a higher risk of HZ and HZ-related complications. Measures to prevent HZ before immunosuppressive treatment initiation should be considered according to Advisory Committee on Immunization Practices recommendations and other professional organizations.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo